Interestingly, a study reported that metabolism of NAD+ is altered in Lmna cardiomyopathy: the Nampt mRNA expression, NAMPT protein expression and NAD+ levels were all reduced in the hearts of mice with cardiomyopathy caused by a Lmna mutation (102). Here, LMNA is linked to cardiomyopathy.